In compliance with Regulation 33 of SEBI (Listing Obligations Disclosure Requirements) Regulation 2015 find attached herewith unaudited financial result for quarter ended 30 June, 2023

pdf

Kabra Drugs Ltd.

14 Aug 2023

18.61

-2.36%

Board Meeting

KABRA DRUGS LTD. - 524322 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

With reference to the above captioned subject, we hereby informed you that the Board of Directors at their meeting held today i.e., Monday, 14th August 2023, 04:00 PM. concluded at 6:30 PM at the registered office of the company have considered and approved the following: The Board of Director have considered and approved the Unaudited Financial Results for quarter ended on 30th June, 2023. In this regard, please find enclosed herewith the unaudited Financial Results along with Limited Review Report on Quarterly Financial Results of the Company pursuant to the Regulation 33 of SEBI (LODR) Regulations, 2015. The Board discussed the compliance of Regulation 32 of SEBI (LODR) Regulations, 2015 and is of the view that the same is not applicable to company as the company has not issued any share by way of Public Issue, Right Issue, Preferential Issue etc. The undertaking of non-applicability of Regulation 32 of SEBI (LODR) Regulations, 2015 is enclosed herewith.

pdf

Kabra Drugs Ltd.

05 Aug 2023

18.61

-2.36%

Board Meeting

KABRA DRUGS LTD. - 524322 - Board Meeting Intimation for Notice Of Board Meeting To Be …

BSE India

KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 ,inter alia, to consider and approve Pursuant to Regulation 29(1) (a) & (2) of the SEBI (LODR) Regulations, 2015, notice is hereby given that a Meeting of the Board of Directors of the Company will be held on Monday, August 14, 2023 at 4:00P.M. to consider and approve, inter-alia, the Un-Audited Financial Results of the Company for the quarter ended on June 30, 2023 Further, the Trading Window for dealing in shares of the Company is already closed and shall open 48 hours after conclusion of the Board Meeting.

pdf

Kabra Drugs Ltd.

12 Jul 2023, 05:38PM

18.61

-2.36%

Company Update

KABRA DRUGS LTD. - 524322 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

In compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we are forwarding herewith a copy of the certificate dated July 7, 2023 received from Skyline Financial Service Private Limited, the Registrar and Share Transfer Agent of the company for the quarter ended June 30,2023

pdf

Kabra Drugs Ltd.

30 Jun 2023

18.61

-2.36%

SAST

KABRA DRUGS LTD. - 524322 - Closure of Trading Window

BSE India

Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 we wish to inform that the trading window shall remain closed from July 1, 2023 till 48 hours after announcement of the Unaudited Financial Results for the Quarter Ended 30th June, 2023. The date of Board Meeting will be informed in due course.

pdf

Kabra Drugs Ltd.

08 Jun 2023

18.61

-2.36%

Board Meeting

KABRA DRUGS LTD. - 524322 - Board Meeting Outcome for Outcome Of The Board Meeting- Audited …

BSE India

With reference to your email dated 7th June 2023 we here by sending you the rectified documets We hereby inform you that, the Meeting of Board of Directors of the Company was held Today viz., Tuesday, 30th of May, 2023 at registered office at 4:00 PM and concluded at 6:00 PM The outcome of the Board meeting, inter alia, is as under: Approval of the Audited Financial Results for the 4th quarter and financial year ended 31st March, 2023 The Board considered and approved the unaudited results for the 4th quarter and financial year ended 31st March, 2023 pursuant to regulation 33 of the listing regulations. A copy of same is enclosed.

pdf

Kabra Drugs Ltd.

08 Jun 2023

18.61

-2.36%

Result

KABRA DRUGS LTD. - 524322 - Financial Results Under Regulation 33/52 Of SEBI (LODR) Regulations 2015, …

BSE India

pdf

Kabra Drugs Ltd.

30 May 2023

18.61

-2.36%

Result

KABRA DRUGS LTD. - 524322 - Outcome Of The Board Meeting 30/05/2023

BSE India

We hereby inform you that, the Meeting of Board of Directors of the Company was held Today viz., Tuesday, 30th of May, 2023 at registered office at 4:00 PM and concluded at 6:00 PM The outcome of the Board meeting, inter alia, is as under: Approval of the Audited Financial Results for the 4th quarter and financial year ended 31st March, 2023 The Board considered and approved the unaudited results for the 4th quarter and financial year ended 31st March, 2023 pursuant to regulation 33 of the listing regulations. A copy of same is enclosed.

pdf

Kabra Drugs Ltd.

30 May 2023

18.61

-2.36%

Company Update

KABRA DRUGS LTD. - 524322 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

This is to inform you that Annual Secretarial Compliance Report under regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018 read with BSE Circular dated 9" May, 2019 is not applicable to our Company. Further, we would like to clarify that our Company is claiming exemption under Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 as Corporate Governance provision shall not apply to listed entities having paid up Equity Share Capital not exceeding Rupees 10 Crores and net worth not exceeding Rupees 25 Crores, as on the day of previous financial year. Hence, we are not required to submit Annual Secretarial Compliance Report as our Company is exempted under Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) regulations, 2015.

pdf

Is Kabra Drugs Ltd. worth buying?

4 Votes:

Buy 50.0%

Sell 25.0%

Hold 25.0%